PREDICTIVE VALUE OF GENOMIC PROFILE IN PATIENTS RECEIVING RAMUCIRUMAB AS SECOND-LINE THERAPY IN ADVANCED OR METASTATIC GASTRIC CANCER

Document | By JML JML
Publihed Date: April.12.2019
Volume 67 (2019) | N° 67-A

reviews & ratings

0 reviews